Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Foster

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
The Journal of Prevention of Alzheimer'S Disease|October 3, 2017
Short-Term Practice Effects and Amyloid Deposition: Providing Information Above and Beyond Baseline CognitionK Duff, D B Hammers, B C A Dalley, et al.
Neurology|October 14, 2009
Relationships between biomarkers in aging and dementiaW J Jagust, S M Landau, L M Shaw, et al.
Neurology|January 5, 2002
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994T Lynch, M Sano, K S Marder, et al.
Neurology|July 2, 2010
Comparing predictors of conversion and decline in mild cognitive impairmentS M Landau, D Harvey, C M Madison, et al.
The Journal of Prevention of Alzheimer'S Disease|December 21, 2018
Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?D A Messner, P Rabins, A C Downing, et al.
The Journal of Prevention of Alzheimer'S Disease|December 21, 2018
Increased Functional Connectivity After Listening to Favored Music in Adults With Alzheimer DementiaJ B King, K G Jones, E Goldberg, et al.
Neurology|November 23, 2000
Treatment of agitation in AD: a randomized, placebo-controlled clinical trialL Teri, R G Logsdon, E Peskind, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
The Journal of Prevention of Alzheimer'S Disease|October 3, 2017
Short-Term Practice Effects and Amyloid Deposition: Providing Information Above and Beyond Baseline CognitionK Duff, D B Hammers, B C A Dalley, et al.
Neurology|October 14, 2009
Relationships between biomarkers in aging and dementiaW J Jagust, S M Landau, L M Shaw, et al.
Neurology|January 5, 2002
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994T Lynch, M Sano, K S Marder, et al.
Neurology|July 2, 2010
Comparing predictors of conversion and decline in mild cognitive impairmentS M Landau, D Harvey, C M Madison, et al.
The Journal of Prevention of Alzheimer'S Disease|December 21, 2018
Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?D A Messner, P Rabins, A C Downing, et al.
The Journal of Prevention of Alzheimer'S Disease|December 21, 2018
Increased Functional Connectivity After Listening to Favored Music in Adults With Alzheimer DementiaJ B King, K G Jones, E Goldberg, et al.
Neurology|November 23, 2000
Treatment of agitation in AD: a randomized, placebo-controlled clinical trialL Teri, R G Logsdon, E Peskind, et al.
Pageof 9